Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 May;64(5):669-81.
doi: 10.1136/ard.2004.028886. Epub 2004 Oct 7.

EULAR Evidence Based Recommendations for the Management of Hip Osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Affiliations
Free PMC article
Review

EULAR Evidence Based Recommendations for the Management of Hip Osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

W Zhang et al. Ann Rheum Dis. .
Free PMC article

Abstract

Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).

Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 European countries. Each participant contributed up to 10 propositions describing key clinical aspects of hip OA management. Ten final recommendations were agreed using a Delphi consensus approach. Medline, Embase, CINAHL, Cochrane Library, and HTA reports were searched systematically to obtain research evidence for each proposition. Where possible, outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. Effect size, rate ratio, number needed to treat, and incremental cost effectiveness ratio were calculated. The quality of evidence was categorised according to the evidence hierarchy. The strength of recommendation was assessed using the traditional A-D grading scale and a visual analogue scale.

Results: Ten key treatment propositions were generated through three Delphi rounds. They included 21 interventions, such as paracetamol, NSAIDs, symptomatic slow acting disease modifying drugs, opioids, intra-articular steroids, non-pharmacological treatment, total hip replacement, osteotomy, and two general propositions. 461 studies were identified from the literature search for the proposed interventions of efficacy, side effects, and cost effectiveness. Research evidence supported 15 interventions in the treatment of hip OA. Evidence specific for the hip was strikingly lacking. Strength of recommendation varied according to category of research evidence and expert opinion.

Conclusion: Ten key recommendations for the treatment of hip OA were developed based on research evidence and expert consensus. The effectiveness and cost effectiveness of these recommendations were evaluated and the strength of recommendation was scored.

Figures

Figure 1
Figure 1
Interventions for hip osteoarthritis from the general literature search. SYSADOA, symptomatic slow acting drugs for OA; THR, total hip replacement.
Figure 2
Figure 2
Study designs for hip OA from the general literature search. EE, economic evaluation; SR, systematic review; RCT, randomised controlled trial; CT, controlled trial.

Comment in

Similar articles

See all similar articles

Cited by 204 articles

See all "Cited by" articles

References

    1. Ann Rheum Dis. 1999 Apr;58(4):201-7 - PubMed
    1. Arthritis Rheum. 1999 Jul;42(7):1361-9 - PubMed
    1. World J Surg. 1999 Aug;23(8):789-93 - PubMed
    1. J Rheumatol. 2000 Jan;27(1):205-11 - PubMed
    1. Pain. 2000 Mar;85(1-2):169-82 - PubMed

MeSH terms

Feedback